COREG CR

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Hypertension

Phase 1

A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.

CompletedNCT00552708

GlaxoSmithKlineHypertension

Start: 2007-09-30End: 2007-12-31Updated: 2010-10-15

Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components

CompletedNCT00556920

GlaxoSmithKlineHypertension

Start: 2007-10-31End: 2007-12-31Updated: 2010-10-15